4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine, 95.0%, 100mg

(R)-BENZYL 2-METHYL-4-OXOPIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

2-(1H-Benzoimidazol-2-yl)-2H-[1,2,4]triazol-3-ylamine, 95.0%, 1g

tert-Butyl[1-(4-bromobenzyl)piperidin-4-yl]methylcarbamate, 95.0%, 1g

3-(2,6-DIMETHYLPYRIDIN-3-YL)PROPANOIC ACID, 95.0%, 250mg

(R)-2-Fluoropropanoic acid, 98%, 250mg

(R)-2-((6-(Benzyl(methyl)amino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol, 97%, 25mg

Hybridisierungs-Flasche, unbeschichtet, Ø 35 x 100 mm, 1 Stück

(S)-(1,4-Dioxan-2-yl)methyl 4-methylbenzenesulfonate, 95.0%, 1g

TERT-BUTYL (4-HYDROXYBICYCLO[2.2.2]OCTAN-1-YL)CARBAMATE, 95.0%, 250mg

5-(2-Fluoro-phenyl)-furan-2-carbaldehyde, 95.0%, 5g

L-Asparagine, N2-acetyl-N-(triphenylmethyl)-, 97%, 1g

3,3-Bis(methoxymethyl)-2,6-dimethylheptane, 95.0%, 250mg